Site name unknown Porto Alegre

Site:	Site name unknown Porto Alegre
Address:
City:	Porto Alegre
State:
Zip:
Country:	Brazil

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
2	Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) (CONVERT)	Completed	Closed	Imatinib	NCT01483014
3	Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (LANGIST)	Terminated	Closed	Nilotinib or Imatinib	NCT00751036